日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors

Epstein-Barr 病毒诱导的异位 CD137 表达有助于鼻咽癌逃避免疫监视并实现嵌合抗原受体的靶向作用

Mukul Prasad #, Sashigala Ponnalagu #, Qun Zeng, Khang Luu, Si Min Lang, Hiu Yi Wong, Man Si Cheng, Meihui Wu, Karthik Mallilankaraman, Radoslaw Mikolaj Sobota, Yan Ting Lim, Loo Chien Wang, Chuan Keng Goh, Kai Xun Joshua Tay, Kwok Seng Loh, Cheng-I Wang, Wen-Hsien Lee, Boon Cher Goh, Chwee Ming Lim

Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization

用于疾病建模和辐射剂量优化的患者来源鼻咽癌类器官

Sasidharan Swarnalatha Lucky, Martin Law, Ming Hong Lui, Jamie Mong, Junli Shi, Sidney Yu, Do Kun Yoon, Shih Kien Djeng, Jiguang Wang, Chwee Ming Lim, Min Han Tan

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation

通过诱导 p53 乙酰化靶向 p53 158 密码子突变型癌症

Li Ren Kong ,Richard Weijie Ong ,Tuan Zea Tan ,Nur Afiqah Binte Mohamed Salleh ,Matan Thangavelu ,Jane Vin Chan ,Lie Yong Judice Koh ,Giridharan Periyasamy ,Jieying Amelia Lau ,Thi Bich Uyen Le ,Lingzhi Wang ,Miyoung Lee ,Srinivasaraghavan Kannan ,Chandra S Verma ,Chwee Ming Lim ,Wee Joo Chng ,David P Lane ,Ashok Venkitaraman ,Huynh The Hung ,Chit Fang Cheok ,Boon Cher Goh

Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli

人类 MAIT 细胞溶细胞效应蛋白协同作用克服大肠杆菌中的卡巴培南耐药性

Caroline Boulouis, Wan Rong Sia, Muhammad Yaaseen Gulam, Jocelyn Qi Min Teo, Yi Tian Png, Thanh Kha Phan, Jeffrey Y W Mak, David P Fairlie, Ivan K H Poon, Tse Hsien Koh, Peter Bergman, Chwee Ming Lim, Lin-Fa Wang, Andrea Lay Hoon Kwa, Johan K Sandberg, Edwin Leeansyah1

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models

泛 CDK 抑制增强顺铂在鼻咽癌细胞系和异种移植模型中的致死率

Nicholas L Syn #, Pei Li Lim #, Li Ren Kong #, Lingzhi Wang, Andrea Li-Ann Wong, Chwee Ming Lim, Thomas Kwok Seng Loh, Gerhard Siemeister, Boon Cher Goh, Wen-Son Hsieh

Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma

通过 TLR3 信号增强西妥昔单抗治疗对 Epstein-Barr 病毒 (EBV) 阳性鼻咽癌的免疫刺激作用

Louise Soo Yee Tan, Benjamin Wong, Nagaraja Rao Gangodu, Andrea Zhe Ern Lee, Anthony Kian Fong Liou, Kwok Seng Loh, Hao Li, Ming Yann Lim, Andres M Salazar, Chwee Ming Lim

TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells

TLR8 刺激增强西妥昔单抗介导的头颈癌细胞自然杀伤细胞裂解以及 EGFR 特异性 CD8+ T 细胞的树突状细胞交叉启动

Ryan M Stephenson, Chwee Ming Lim, Maura Matthews, Gregory Dietsch, Robert Hershberg, Robert L Ferris

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells

TLR3 激动剂可提高西妥昔单抗对 EGFR+ 头颈癌细胞的免疫刺激潜力

Chwee Ming Lim, Ryan Stephenson, Andres M Salazar, Robert L Ferris